Jonghun John Lee1, Brendan C Dickson2, Boraiah Sreeharsha1, Rebecca A Gladdy3, Seng Thipphavong1. 1. 1 Joint Department of Medical Imaging, Women's College Hospital, University of Toronto, 76 Grenville St, Rm 2238, Toronto, ON, M5B 1S2, Canada. 2. 2 Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. 3. 3 Department of Surgery, Division of General Surgery, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Abstract
OBJECTIVE: Myelolipoma is a benign tumor composed of fatty and hematopoietic elements. Presacral myelolipoma is rare, with fewer than 40 cases reported in the English literature. It is important to make an accurate diagnosis because there are malignant diseases included in the differential diagnosis of a presacral fatty mass, particularly liposarcoma. CONCLUSION: The combination of a well-encapsulated fat-containing presacral mass, lack of coinciding hematologic disease, and uptake on sulfur colloid scintigraphy support the diagnosis of a presacral myelolipoma.
OBJECTIVE:Myelolipoma is a benign tumor composed of fatty and hematopoietic elements. Presacral myelolipoma is rare, with fewer than 40 cases reported in the English literature. It is important to make an accurate diagnosis because there are malignant diseases included in the differential diagnosis of a presacral fatty mass, particularly liposarcoma. CONCLUSION: The combination of a well-encapsulated fat-containing presacral mass, lack of coinciding hematologic disease, and uptake on sulfur colloid scintigraphy support the diagnosis of a presacral myelolipoma.